Literature DB >> 22127496

Norepinephrine promotes the β1-integrin-mediated adhesion of MDA-MB-231 cells to vascular endothelium by the induction of a GROα release.

Carina Strell1, Bernd Niggemann, Melanie J Voss, Desmond G Powe, Kurt S Zänker, Frank Entschladen.   

Abstract

The migratory activity of tumor cells and their ability to extravasate from the blood stream through the vascular endothelium are important steps within the metastasis cascade. We have shown previously that norepinephrine is a potent inducer of the migration of MDA-MB-468 human breast carcinoma cells and therefore investigated herein, whether the interaction of these cells as well as MDA-MB-231 and MDA-MB-435S human breast carcinoma cells with the vascular endothelium is affected by this neurotransmitter as well. By means of a flow-through assay under physiologic flow conditions, we show that norepinephrine induces an increase of the adhesion of the MDA-MB-231 cells, but not of MDA-MB-468 and MDA-MB-435S cells to human pulmonary microvascular endothelial cells (HMVEC). The adhesion of MDA-MB-231 cells was based on a norepinephrine-mediated release of GROα from HMVECs. GROα caused a β1-integrin-mediated increase of the adhesion of MDA-MB-231 cells. Most interestingly, this effect of norepinephrine, similar to the aforementioned induction of migration in MDA-MB-468 cells, was mediated by β-adrenergic receptors and therefore abrogated by β-blockers. In conclusion, norepinephrine has cell line-specific effects with regard to certain steps of the metastasis cascade, which are conjointly inhibited by clinically established β-blockers. Therefore, these results may deliver a molecular explanation for our recently published retrospective data analysis of patients with breast cancer which shows that β-blockers significantly reduce the development of metastases. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22127496     DOI: 10.1158/1541-7786.MCR-11-0130

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  16 in total

1.  The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms.

Authors:  Zhen Lu; Robert C Bast
Journal:  Cell Adh Migr       Date:  2013-01-28       Impact factor: 3.405

2.  A high-throughput mechanofluidic screening platform for investigating tumor cell adhesion during metastasis.

Authors:  A Spencer; C Spruell; S Nandi; M Wong; M Creixell; A B Baker
Journal:  Lab Chip       Date:  2016-01-07       Impact factor: 6.799

3.  Norepinephrine inhibits migration and invasion of human glioblastoma cell cultures possibly via MMP-11 inhibition.

Authors:  Jing Zhong; Weiran Shan; Zhiyi Zuo
Journal:  Brain Res       Date:  2021-01-27       Impact factor: 3.252

Review 4.  Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease.

Authors:  M Archer; N Dogra; Z Dovey; T Ganta; H-S Jang; J A Khusid; A Lantz; M Mihalopoulos; J A Stockert; A Zahalka; L Björnebo; S Gaglani; M R Noh; S A Kaplan; R Mehrazin; K K Badani; P Wiklund; K Tsao; D J Lundon; N Mohamed; F Lucien; B Padanilam; M Gupta; A K Tewari; N Kyprianou
Journal:  Cell Commun Signal       Date:  2021-07-20       Impact factor: 5.712

5.  Endothelial integrin α3β1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macromolecular signaling complex formation at the endothelial cell membrane.

Authors:  Olga V Glinskii; Feng Li; Landon S Wilson; Stephen Barnes; Kate Rittenhouse-Olson; Joseph J Barchi; Kenneth J Pienta; Vladislav V Glinsky
Journal:  Oncotarget       Date:  2014-03-15

6.  Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines.

Authors:  Lucía Gargiulo; Sabrina Copsel; Ezequiel M Rivero; Céline Galés; Jean-Michel Sénard; Isabel A Lüthy; Carlos Davio; Ariana Bruzzone
Journal:  Oncotarget       Date:  2014-10-30

7.  Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.

Authors:  Pan Pantziarka; Gauthier Bouche; Vidula Sukhatme; Lydie Meheus; Ilse Rooman; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2016-10-12

8.  To block it, or not to block it?

Authors:  Artur Wnorowski
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-27       Impact factor: 4.553

9.  After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma.

Authors:  Jian Kong; Lingqun Kong; Jinge Kong; Shan Ke; Jun Gao; Xuemei Ding; Lemin Zheng; Huichuan Sun; Wenbing Sun
Journal:  J Transl Med       Date:  2012-11-21       Impact factor: 5.531

10.  Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade.

Authors:  Cecilia Choy; John L Raytis; David D Smith; Matthew Duenas; Josh Neman; Rahul Jandial; Michael W Lew
Journal:  Oncol Rep       Date:  2016-03-28       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.